drugset / Trial / NCT04756232

Cholinergic Mechanisms of Attention in Aging

NCT04756232

Phase 0 Completed 19 enrolled Vanderbilt University Medical Center
RandomizedCrossoverTriple-blindBasic science

Summary

This study will use an anticholinergic pharmacological probe to examine attention network function in SCD using EEG. The overall hypothesis is that in older adults with SCD, normal cognitive performance is maintained by compensatory attention network activity, supported by enhanced cholinergic function. The investigators anticipate that SCD will be associated with greater compensatory attention network activity and that disrupting this compensatory process through anticholinergic challenge will result in a greater negative effect on attentional performance (Attention Network Test, ANT) and attention network functioning (EEG) in older adults with SCD compared to those without SCD.

Timeline

Start
2022-04-21
Primary completion
2025-04-30
Completion
2025-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mecamylamine Small molecule 20 mg Oral